Lisa Porter

Lisa Porter is an Associate Professor in the Department of Biomedical Sciences at the University of Windsor, affiliated with the Faculty of Science. She serves as Executive Director of the WE-Spark Health Institute and Scientific Director of the Windsor Cancer Research Group. Her research focuses on cancer biology, particularly glioblastoma, breast cancer, and cell cycle regulation. She collaborates with Windsor Regional Hospital and St. Joseph’s Health Care London, and leads initiatives in translational health science and public health surveillance.

• Affiliations: WE-Spark Health Institute, Windsor Cancer Research Group, St. Joseph’s Health Care London
• Education: Ph.D. in Biological Sciences (not explicitly stated but implied by role)

Research interests include cancer stem cells, therapeutic resistance, and molecular pathways in oncogenesis. She has pioneered zebrafish models for tumor studies and developed wastewater surveillance systems for pandemic monitoring. Porter’s work bridges academic research with clinical practice, emphasizing community engagement and cross-border collaboration.

Her most recent articles (2024–2025) highlight advancements in glioma stem cell modeling, Spy1 protein’s role in cancer progression, and public health data platforms. Awards include the Ontario Medical Association Centennial Award (2024) and the David Kelly Award for Community Service (2018).

Porter mentors numerous students and oversees grants totaling millions, including a $15M project on pandemic preparedness. She advocates for translational research and has established programs like the 'Cancer Researcher for a Day' initiative for survivors.

Labs/Teams: Porter Lab, WE-Spark Health Institute, and collaborations with clinical partners in Windsor-Essex and London.